Charles River Laboratories International Inc (NYSE:CRL)

76.67
Delayed Data
As of Feb 27
 -0.10 / -0.13%
Today’s Change
49.60
Today|||52-Week Range
77.17
+20.47%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$3.6B

Company Description

Charles River Laboratories International, Inc. provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. The company operates its business through two reporting segments: Research Models and Services and Preclinical Services. The Research Models and Services segment supplies research models to the drug development industry. It also provides a variety of related services that are designed to assist its clients in supporting the use of research models in drug discovery and development. The Research Models and Services segment comprises of Research Models, Research Model Services, and Endotoxin and Microbial Detection. The Preclinical Services segment provides services that enable its clients to outsource their critical, regulatory-required safety assessment and related drug development activities. Charles River Laboratories was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.

Contact Information

Charles River Laboratories International, Inc.
251 Ballardvale Street
Wilmington Massachusetts 01887
P:(781) 222-6000
Investor Relations:
(781) 222-6190

Employees

Shareholders

Mutual fund holders59.34%
Other institutional40.61%
Individual stakeholders3.82%

Top Executives

James C. FosterChairman, President & Chief Executive Officer
Thomas F. AckermanChief Financial Officer & Executive Vice President
Nancy A. GillettChief Scientific Officer & Executive VP
Arthur C. HubbsChief Information Officer & Senior Vice President
David P. JohstSecretary & Chief Administrative Officer

To view my watchlist

Not a member yet?

Sign up now for a free account